Finance

Lists
HRMY:NASDAQ
Harmony Biosciences Holdings Inc
၃၉.၃၆ US$
-၁.၄၀%
(-၀.၅၆) 1D
၃၉.၃၆ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၆, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HRMY...
Open
၄၀.၀၉ US$
High
၄၀.၃၅ US$
Low
၃၈.၉၁ US$
Mkt. cap
၂၂၇.၆၁ ဋေ
Avg. vol.
၉.၈၃ သိန်း
Volume
၅.၀၁ သိန်း
P/E ratio
၁၂.၇၃
52-wk high
၄၃.၄၉ US$
52-wk low
၂၅.၅၂ US$
EPS
၃.၀၉ US$
Beta
၁.၀၁
Shares outstanding
၅.၈၂ ကုဋေ
No. of employees
၂၉၃
Open
၄၀.၀၉ US$
High
၄၀.၃၅ US$
Low
၃၈.၉၁ US$
Mkt. cap
၂၂၇.၆၁ ဋေ
Avg. vol.
၉.၈၃ သိန်း
Volume
၅.၀၁ သိန်း
P/E ratio
၁၂.၇၃
52-wk high
၄၃.၄၉ US$
52-wk low
၂၅.၅၂ US$
EPS
၃.၀၉ US$
Beta
၁.၀၁
Shares outstanding
၅.၈၂ ကုဋေ
No. of employees
၂၉၃
News stories
From web sources and news partners
Zacks
Zacks
·
ပြီးခဲ့သည့် ၄ နာရီ
HRMY vs. CSLLY: Which Stock Is the Better Value Option?
Zacks
Zacks
·
ပြီးခဲ့သည့် ၆ နာရီ
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?
About Harmony Biosciences Holdings Inc
CEO-
Employees၂၉၃
Founded၂၀၁၇
Headquarters-
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to HRMY in the past 3 months
Buy
Buy
4
Hold
4
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HRMY in the last 3 months.
Highest
Current ၃၉.၃၆ US$
၆၀.၀၀ US$ (+၅၂.၄၄%)
Average
၄၄.၀၀ US$ (+၁၁.၇၉%)
Lowest
၃၀.၀၀ US$ (-၂၃.၇၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Hoang
Deutsche Bank
Hold
Maintained
၄၂.၀၀ US$
+၆.၇%
10/01/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
၅၁.၀၀ US$
+၂၉.၆%
09/25/2026
Ami Fadia
Needham
Buy
Maintained
၅၀.၀၀ US$
+၂၇%
09/24/2026
Rudy Li
Wolfe Research
Buy
Initiated
၆၀.၀၀ US$
+၅၂.၄%
08/26/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
၅၅.၀၀ US$
+၃၉.၇%
08/12/2026
Danielle Brill
Truist Financial
Hold
Maintained
၃၄.၀၀ US$
-၁၃.၆%
08/05/2026
So Youn Shim
UBS
Hold
Maintained
၃၇.၀၀ US$
-၆%
08/05/2026
Jason Gerberry
Bank of America Securities
Sell
Reiterated
၃၀.၀၀ US$
-၂၃.၈%
08/04/2026
Corinne Johnson
Goldman Sachs
Hold
Maintained
၃၇.၀၀ US$
-၆%
07/16/2026
Jay Olson
Oppenheimer
Buy
Maintained
၇၂.၀၀ US$
+၈၂.၉%
04/22/2026
David Amsellem
Piper Sandler
Buy
Reiterated
၄၆.၀၀ US$
+၁၆.၉%
04/22/2026
Andreas Argyrides
Oppenheimer
Buy
Reiterated
၆၂.၀၀ US$
+၅၇.၅%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂၃.၉၅ ကုဋေ
၂၄.၃၈ ကုဋေ
၂၁.၅၄ ကုဋေ
၂၆.၁၃ ကုဋေ
Cost of goods sold
၅.၉၆ ကုဋေ
၆.၈၅ ကုဋေ
၄.၄၅ ကုဋေ
၆.၃၂ ကုဋေ
Cost of revenue
၅.၉၆ ကုဋေ
၆.၈၅ ကုဋေ
၄.၄၅ ကုဋေ
၆.၃၂ ကုဋေ
Research and development expenses
၅.၅၀ ကုဋေ
၄.၉၉ ကုဋေ
၆.၉၄ ကုဋေ
၄.၆၆ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅.၉၄ ကုဋေ
၈.၆၇ ကုဋေ
၆.၄၂ ကုဋေ
၆.၂၂ ကုဋေ
Operating expense
၁၁.၄၃ ကုဋေ
၁၃.၆၇ ကုဋေ
၁၃.၃၆ ကုဋေ
၁၀.၈၈ ကုဋေ
Total operating expenses
၁၇.၄၀ ကုဋေ
၂၀.၅၂ ကုဋေ
၁၇.၈၁ ကုဋေ
၁၇.၂၀ ကုဋေ
Operating income
၆.၅၅ ကုဋေ
၃.၈၆ ကုဋေ
၃.၇၃ ကုဋေ
၈.၉၃ ကုဋေ
Other non operating income
-၁.၀၆ သိန်း
-၁.၀၅ သိန်း
-၁.၂၇ သိန်း
-၅.၃၀ သောင်း
EBT including unusual items
၆.၇၅ ကုဋေ
၄.၀၈ ကုဋေ
၃.၉၇ ကုဋေ
၉.၃၃ ကုဋေ
EBT excluding unusual items
၆.၇၅ ကုဋေ
၄.၀၈ ကုဋေ
၃.၉၇ ကုဋေ
၉.၃၃ ကုဋေ
Income tax expense
၁.၆၆ ကုဋေ
၁.၈၃ ကုဋေ
၇.၂၀ သန်း
၁.၇၈ ကုဋေ
Effective tax rate
၂၄.၆၃%
၄၄.၈၃%
၁၈.၁၄%
၁၉.၁၂%
Other operating expenses
-
-
-
-
Net income
၅.၀၉ ကုဋေ
၂.၂၅ ကုဋေ
၃.၂၅ ကုဋေ
၇.၅၄ ကုဋေ
Net profit margin
၂၁.၂၄%
၉.၂၂%
၁၅.၀၈%
၂၈.၈၇%
Earnings per share
၁.၀၈
၀.၅၇
၀.၇၉
၁.၅၀
Interest and investment income
၅.၇၃ သန်း
၅.၈၅ သန်း
၅.၇၆ သန်း
၇.၀၇ သန်း
Interest expense
-၃.၆၂ သန်း
-၃.၅၅ သန်း
-၃.၂၃ သန်း
-၃.၀၇ သန်း
Net interest expenses
၂.၁၁ သန်း
၂.၃၁ သန်း
၂.၅၂ သန်း
၄.၀၀ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၇.၁၅ ကုဋေ
၄.၆၀ ကုဋေ
၄.၃၃ ကုဋေ
၉.၅၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ